What if you'd held OTLK?
A $1,000 investment in Outlook Therapeutics, Inc. (OTLK) at the month-end close of 2016-06 would be worth $1.27 at the close of 2026-08 — -99.9% total return, dividends reinvested. The same $1,000 in the S&P 500 would be worth $3,672.
Your scenario
Result
If you'd bought $1,000 at the start of each year
Value of $1,000 invested on January 1 of each year, held to 2026-08, dividends included.
Every year, $1,000 from 2016
| Year | Value of $1,000 | Year return |
|---|---|---|
| 2016 | $1,000 | — |
| 2017 | $432 | -56.8% |
| 2018 | $166 | -61.5% |
| 2019 | $24.50 | -85.3% |
| 2020 | $53.99 | +120.3% |
| 2021 | $56.48 | +4.6% |
| 2022 | $44.85 | -20.6% |
| 2023 | $16.36 | -63.5% |
| 2024 | $3.92 | -76.0% |
| 2025 | $3.28 | -16.4% |
| 2026 | $1.43 | -56.3% |
Best and worst month-end to buy
The best single month-end close to have bought OTLK was 2026-03 ($0.21): $1,000 then is $3,350 today. The worst was 2016-08 ($758): $1,000 then is $0.91.
FAQ
What would $1,000 in OTLK be worth today?
A $1,000 investment in Outlook Therapeutics, Inc. (OTLK) at the start of 2016 would be worth about $1.27 today, a total return of -99.9%. Dividends are reinvested in these figures.
What were the best and worst years for OTLK?
Outlook Therapeutics, Inc. (OTLK)'s strongest calendar year since 2016 was 2020, a +120.3% return — $1,000 held through that year became about $2,203 by year-end. Its weakest year was 2019, at -85.3%.
Does the calculator include dividends and splits?
Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.
How much would $100 per month in OTLK have grown?
Investing $100 at the end of every month since 2016-06 would have grown to about $2,192 on $12,300 invested.
Did OTLK beat the S&P 500?
Over the same period, $1,000 in the S&P 500 index would be worth $3,672. OTLK trailed the S&P 500 by +100.0% in total return.
Is this investment advice?
No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.
Methodology
Outlook Therapeutics, Inc. (OTLK) historical total-return data from 2016-06 to 2026-08, reduced to month-end closes for the tables above.
Returns use adjusted close prices from Yahoo Finance historical data — adjusted for stock splits and reinvested dividends — the same convention used by major brokerages. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (Yahoo Finance): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.
Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.
What if you'd held…
Data: adjusted close prices via Yahoo Finance. As of 2026-08. Not financial advice.